196 related articles for article (PubMed ID: 22777615)
1. Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.
Al-Humadi H; Theocharis S; Dontas I; Stolakis V; Zarros A; Kyriakaki A; Al-Saigh R; Liapi C
Dig Dis Sci; 2012 Dec; 57(12):3168-77. PubMed ID: 22777615
[TBL] [Abstract][Full Text] [Related]
2. Combined thirty-day exposure to thioacetamide and choline-deprivation alters serum antioxidant status and crucial brain enzyme activities in adult rats.
Liapi C; Al-Humadi H; Zarros A; Galanopoulou P; Stolakis V; Gkrouzman E; Mellios Z; Skandali N; Anifantaki F; Tsakiris S
Metab Brain Dis; 2009 Sep; 24(3):441-51. PubMed ID: 19697115
[TBL] [Abstract][Full Text] [Related]
3. Caffeine intake decreases oxidative stress and inflammatory biomarkers in experimental liver diseases induced by thioacetamide: Biochemical and histological study.
Amer MG; Mazen NF; Mohamed AM
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):13-24. PubMed ID: 28281876
[TBL] [Abstract][Full Text] [Related]
4. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
[TBL] [Abstract][Full Text] [Related]
5. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
Aher JS; Khan S; Jain S; Tikoo K; Jena G
Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
[TBL] [Abstract][Full Text] [Related]
6. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.
Hong F; Si C; Gao P; Cederbaum AI; Xiong H; Lu Y
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):33-43. PubMed ID: 26363552
[TBL] [Abstract][Full Text] [Related]
7. Effect of coriander on thioacetamide-induced hepatotoxicity in rats.
Moustafa AH; Ali EM; Moselhey SS; Tousson E; El-Said KS
Toxicol Ind Health; 2014 Aug; 30(7):621-9. PubMed ID: 23042592
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotective activity of Lactéol® forte and quercetin dihydrate against thioacetamide-induced hepatic cirrhosis in male albino rats.
Saad HM; Oda SS; Alexiou A; Papadakis M; Mahmoud MH; Batiha GE; Khalifa E
J Cell Mol Med; 2024 Apr; 28(8):e18196. PubMed ID: 38534093
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats.
Margeli AP; Skaltsas SD; Spiliopoulou CA; Mykoniatis MG; Theocharis SE
Liver; 1999 Dec; 19(6):519-25. PubMed ID: 10661686
[TBL] [Abstract][Full Text] [Related]
10. Chronic vitamin C insufficiency aggravated thioacetamide-induced liver fibrosis in gulo-knockout mice.
Kim JH; Jeong YJ; Hong JM; Kim HR; Kang JS; Lee WJ; Hwang YI
Free Radic Biol Med; 2014 Feb; 67():81-90. PubMed ID: 24184603
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage.
Sayan M; Karabulut D; Özdamar S
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22450. PubMed ID: 31967703
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of kaerophyllin against liver fibrogenesis in rats.
Lee TF; Lin YL; Huang YT
Eur J Clin Invest; 2012 Jun; 42(6):607-16. PubMed ID: 22103576
[TBL] [Abstract][Full Text] [Related]
13. Previous liver regeneration induces fibro-protective mechanisms during thioacetamide-induced chronic liver injury.
Gratte FD; Pasic S; Abu Bakar NDB; Gogoi-Tiwari J; Liu X; Carlessi R; Kisseleva T; Brenner DA; Ramm GA; Olynyk JK; Tirnitz-Parker JEE
Int J Biochem Cell Biol; 2021 May; 134():105933. PubMed ID: 33540107
[TBL] [Abstract][Full Text] [Related]
14. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
Shaker ME; Shiha GE; Ibrahim TM
Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
[TBL] [Abstract][Full Text] [Related]
15. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
[TBL] [Abstract][Full Text] [Related]
16. Depletion of Hepatic Macrophages Aggravates Liver Lesions Induced in Rats by Thioacetamide (TAA).
Golbar HM; Izawa T; Wijesundera KK; Bondoc A; Tennakoon AH; Kuwamura M; Yamate J
Toxicol Pathol; 2016 Feb; 44(2):246-58. PubMed ID: 26957569
[TBL] [Abstract][Full Text] [Related]
17. Role of quercetin in preventing thioacetamide-induced liver injury in rats.
de David C; Rodrigues G; Bona S; Meurer L; González-Gallego J; Tuñón MJ; Marroni NP
Toxicol Pathol; 2011 Oct; 39(6):949-57. PubMed ID: 21885874
[TBL] [Abstract][Full Text] [Related]
18. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats.
Theocharis SE; Margeli AP; Agapitos EV; Mykoniatis MG; Kittas CN; Davaris PS
Scand J Gastroenterol; 1998 Jun; 33(6):656-63. PubMed ID: 9669640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
